This announcement is a separate document:
中國抗體-B：自願公告 SM17在中國I期臨床試驗完成首個隊列的健康受試者給藥
SINOMAB BIO-B: VOLUNTARY ANNOUNCEMENT FIRST COHORT OF THE HEALTHY SUBJECTS DOSED IN A PHASE I CLINICAL TRIAL OF SM17 IN CHINA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.